Skip to content

Effect of Traditional Chinese Medicine intervention on prognosis of patients with metastatic colorectal cancer: a retrospective cohort study

Effect of Traditional Chinese Medicine intervention on prognosis of patients with metastatic colorectal cancer: a retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17010497
Enrollment
Unknown
Registered
2017-01-22
Start date
2017-01-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Traditional Chinese medicine and Western medicine group:Traditional Chinese medicine and Western medicine

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) stage IV colorectal cancer patients with a genetic status of KRAS, NRAS, and BRAF were identified with a definite pathological diagnosis; (2) Karnofsky score more than 70 points; (3) 18 years of age or older.

Exclusion criteria

Exclusion criteria: (1) patients with severe heart, liver, lung, kidney and other organs dysfunction caused by disease; (2) patients with complete intestinal obstruction, or those who cannot be taken orally for various reasons; (3) prior to or after the history of other malignancies, except for basal cell carcinoma and cervical carcinoma in situ; (4) patients with serious information loss, the impact of efficacy and safety evaluation.

Design outcomes

Primary

MeasureTime frame
Overall Survival;Progression-free Survival;

Countries

China

Contacts

Public ContactZhang Tong

Xiyuan Hospital of China Academy of Chinese Medical Sciences

ashtray7654@126.com+86 18710047520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026